155 related articles for article (PubMed ID: 34859984)
21. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
[TBL] [Abstract][Full Text] [Related]
22. Hedgehog Pathway Inhibition.
Sekulic A; Von Hoff D
Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
[TBL] [Abstract][Full Text] [Related]
23. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
Zhang H; Sun Z; Liu Z; Song C
Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039
[TBL] [Abstract][Full Text] [Related]
24. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.
Von Hoff DD; LoRusso PM; Rudin CM; Reddy JC; Yauch RL; Tibes R; Weiss GJ; Borad MJ; Hann CL; Brahmer JR; Mackey HM; Lum BL; Darbonne WC; Marsters JC; de Sauvage FJ; Low JA
N Engl J Med; 2009 Sep; 361(12):1164-72. PubMed ID: 19726763
[TBL] [Abstract][Full Text] [Related]
26. A novel protein encoded by circular SMO RNA is essential for Hedgehog signaling activation and glioblastoma tumorigenicity.
Wu X; Xiao S; Zhang M; Yang L; Zhong J; Li B; Li F; Xia X; Li X; Zhou H; Liu D; Huang N; Yang X; Xiao F; Zhang N
Genome Biol; 2021 Jan; 22(1):33. PubMed ID: 33446260
[TBL] [Abstract][Full Text] [Related]
27. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
[TBL] [Abstract][Full Text] [Related]
28. Sonic Hedgehog Activates Phospholipase A2 to Enhance Smoothened Ciliary Translocation.
Arensdorf AM; Dillard ME; Menke JM; Frank MW; Rock CO; Ogden SK
Cell Rep; 2017 Jun; 19(10):2074-2087. PubMed ID: 28591579
[TBL] [Abstract][Full Text] [Related]
29. Mir-326 potentiates radiosensitivity of cervical squamous cell carcinoma through downregulating SMO expression in the Hedgehog signaling pathway.
Zhang J; Li Y; Ren Y; Han H; Li J
Genes Genomics; 2022 Aug; 44(8):981-991. PubMed ID: 35751784
[TBL] [Abstract][Full Text] [Related]
30. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
[TBL] [Abstract][Full Text] [Related]
31. Segmental basaloid follicular hamartomas derive from a post-zygotic SMO p.L412F pathogenic variant and express hair follicle development-related proteins in a pattern that distinguish them from basal cell carcinomas.
Atzmony L; Ugwu N; Bercovitch LG; Robinson-Bostom L; Ko CJ; Myung P; Choate KA
Am J Med Genet A; 2022 Dec; 188(12):3525-3530. PubMed ID: 35972041
[TBL] [Abstract][Full Text] [Related]
32. Bi-allelic Variations of SMO in Humans Cause a Broad Spectrum of Developmental Anomalies Due to Abnormal Hedgehog Signaling.
Le TL; Sribudiani Y; Dong X; Huber C; Kois C; Baujat G; Gordon CT; Mayne V; Galmiche L; Serre V; Goudin N; Zarhrate M; Bole-Feysot C; Masson C; Nitschké P; Verheijen FW; Pais L; Pelet A; Sadedin S; Pugh JA; Shur N; White SM; El Chehadeh S; Christodoulou J; Cormier-Daire V; Hofstra RMW; Lyonnet S; Tan TY; Attié-Bitach T; Kerstjens-Frederikse WS; Amiel J; Thomas S
Am J Hum Genet; 2020 Jun; 106(6):779-792. PubMed ID: 32413283
[TBL] [Abstract][Full Text] [Related]
33. Molecular testing in metastatic basal cell carcinoma.
Verkouteren BJA; Wakkee M; van Geel M; van Doorn R; Winnepenninckx VJ; Korpershoek E; Mooyaart AL; Reyners AKL; Terra JB; Aarts MJB; Reinders MGHC; Mosterd K
J Am Acad Dermatol; 2021 Nov; 85(5):1135-1142. PubMed ID: 31870915
[TBL] [Abstract][Full Text] [Related]
34. Hedgehog signaling in basal cell carcinoma.
Otsuka A; Levesque MP; Dummer R; Kabashima K
J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
[TBL] [Abstract][Full Text] [Related]
35. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
[TBL] [Abstract][Full Text] [Related]
36. Sonidegib phosphate: new approval for basal cell carcinoma.
Tibes R
Drugs Today (Barc); 2016 May; 52(5):295-303. PubMed ID: 27376162
[TBL] [Abstract][Full Text] [Related]
37. Hypomorphic Smo mutant with inefficient ciliary enrichment disrupts the highest level of vertebrate Hedgehog response.
Gigante ED; Long AB; Ben-Ami J; Caspary T
Dev Biol; 2018 May; 437(2):152-162. PubMed ID: 29571613
[TBL] [Abstract][Full Text] [Related]
38. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
39. RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.
Zhao X; Ponomaryov T; Ornell KJ; Zhou P; Dabral SK; Pak E; Li W; Atwood SX; Whitson RJ; Chang AL; Li J; Oro AE; Chan JA; Kelleher JF; Segal RA
Cancer Res; 2015 Sep; 75(17):3623-35. PubMed ID: 26130651
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma.
Yin VT; Esmaeli B
Curr Pharm Des; 2017; 23(4):655-659. PubMed ID: 27928965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
